Diabetes Care 47 , 13501359 (2024)
This is great and to truly compete here in the end, is by having the right supply chain
According to the UK SmPC, the most common side effects include: Nausea (very common, affecting more than 1 in 10 people): Usually most pronounced during the first few weeks of treatment and often diminishes with continued use Diarrhoea (common, affecting up to 1 in 10 people): Typically mild to moderate in severity Vomiting (common): More frequent at higher doses Constipation (common): May occur alongside other gastrointestinal effects Abdominal pain or discomfort (common): Relatively frequent during treatment initiation Decreased appetite (very common): An expected effect related to the medication's action Dyspepsia/indigestion (common): May contribute to discomfort after eating Beyond gastrointestinal effects, other recognised adverse reactions include injection site reactions (redness, itching, or swelling at the subcutaneous injection site), fatigue , and dizziness
Seales que pueden sugerir alteraciones en la funcin del GLP-1 Es importante aclarar que no existe una prueba clnica rutinaria para medir directamente los niveles de GLP-1 en la prctica mdica habitual
Without insurance but using the Novo Nordisk savings card: varies by eligibility
